New drug for Duchenne muscular dystrophy clears phase 1 clinical trial testing in boys

Patients with Duchenne muscular dystrophy (DMD) have few treatment options. Medications currently available or in development either target only a subset of DMD patients with a particular genetic mutation or cause significant side effects.